Position in ABBV
as of Jun 30, 2026
· filed Aug 19, 2026
Position Value
$2,696,322
+$387,014 QoQ
Shares Held
10,715
+0.9% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.64%
of 13F equity value
Holder Rank
#1,725
of 4,153 holders
Holding Since
Jun 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Field & Main Bank holds $26,958,516 across 8 Drug Manufacturers - General names. ABBV ranks #3 (10.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
7,859 | $9,426,320 | |
| 2 | JNJ |
Johnson & Johnson
|
36,353 | $9,232,570 | |
| 3 | ABBV |
AbbVie Inc.
This page
|
10,715 | $2,696,322 | |
| 4 | AMGN |
Amgen Inc
|
7,076 | $2,562,361 | |
| 5 | MRK |
Merck & Co., Inc.
|
19,053 | $2,448,310 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
9,151 | $527,280 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
300 | $37,902 | |
| 8 | PFE |
Pfizer Inc
|
1,140 | $27,451 |
All Filings in ABBV
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,696,322 | 10,715 | Shares | Sole | 2026-08-19 | |
| 2026-03-31 | $2,309,308 | 10,618 | Shares | Sole | 2026-04-10 | |
| 2025-12-31 | $2,465,406 | 10,790 | Shares | Sole | 2026-01-28 | |
| 2025-09-30 | $2,459,185 | 10,621 | Shares | Sole | 2025-11-03 | |
| 2025-06-30 | $1,929,519 | 10,395 | Shares | Sole | 2025-08-04 | |
| 2025-03-31 | $2,182,150 | 10,415 | Shares | Sole | 2025-04-23 | |
| 2024-12-31 | $1,960,030 | 11,030 | Shares | Sole | 2025-01-23 | |
| 2024-09-30 | $2,241,398 | 11,350 | Shares | Sole | 2024-11-01 | |
| 2024-06-30 | $1,998,208 | 11,650 | Shares | Sole | 2024-07-25 | |
| 2024-03-31 | $2,116,729 | 11,624 | Shares | Sole | 2024-04-29 | |
| 2023-12-31 | $1,951,846 | 12,595 | Shares | Sole | 2024-02-05 | |
| 2023-09-30 | $1,942,549 | 13,032 | Shares | Sole | 2023-10-12 | |
| 2023-06-30 | $1,826,264 | 13,555 | Shares | Sole | 2023-07-26 | |
| 2023-03-31 | $2,184,962 | 13,710 | Shares | Sole | 2023-04-19 | |
| 2022-12-31 | $2,252,035 | 13,935 | Shares | Sole | 2023-01-19 | |
| 2022-09-30 | $1,914,371 | 14,264 | Shares | Sole | 2022-10-25 | |
| 2022-06-30 | $2,198,458 | 14,354 | Shares | Sole | 2022-07-18 | |
| 2022-03-31 | $2,361,131 | 14,565 | Shares | Sole | 2022-04-21 | |
| 2021-12-31 | $2,022,199 | 14,935 | Shares | Sole | 2022-02-01 | |
| 2021-09-30 | $1,566,811 | 14,525 | Shares | Sole | 2021-10-14 | |
| 2021-06-30 | $1,636,659 | 14,530 | Shares | Sole | 2021-07-15 | |
| 2021-03-31 | $1,525,360 | 14,095 | Shares | Sole | 2021-04-30 | |
| 2020-12-31 | $1,460,453 | 13,630 | Shares | Sole | 2021-02-25 | |
| 2020-09-30 | $1,199,982 | 13,700 | Shares | Sole | 2020-10-22 | |
| 2020-06-30 | $998,490 | 10,170 | Shares | Sole | 2020-08-12 | |
| No filing history on record for this holder in this stock. | ||||||